Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Displaying 41 questions Show Answers

Order by |

Question reference: S6W-26823

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Friday, 12 April 2024
Current Status: Answer expected on 13 May 2024

To ask the Scottish Government what recent discussions it has had with COSLA regarding the presence of asbestos in schools and other public buildings.

Question reference: S6O-03318

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 10 April 2024
Current Status: Taken in the Chamber on 18 April 2024

To ask the Scottish Government what it is doing to support childcare groups that provide afterschool care and care outwith school term times.

Question reference: S6W-26529

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 27 March 2024
Current Status: Answered by Richard Lochhead on 9 April 2024

To ask the Scottish Government what progress has been made on the roll-out of superfast broadband in Clydebank and Milngavie.

Figures provided by Ofcom.org.uk, show that, as of September 2023, 98% of premises in the Clydebank and Milngavie constituency could access fixed line superfast broadband.

This is, in part, thanks to publicly-funded digital programmes which have connected around one million properties across Scotland to fibre broadband to date, with the vast majority receiving superfast speeds. This includes the Digital Scotland Superfast Broadband (DSSB) programme, which delivered over 10,000 connections in the constituency of Clydebank and Milngavie.

Our Scottish Government commitment to deliver 100% superfast broadband across Scotland is delivered through the three strands of activity that make up the Reaching 100% (R100) programme – the three R100 contracts (North, Central and South), our demand-led R100 Scottish Broadband Voucher Scheme (SBVS) and the ongoing expansion of commercial coverage including newly emerging technologies such as Low Earth Orbit (LEO) satellite connections.

As a result, all homes and businesses should now be able to access superfast broadband.

Question reference: S6O-03198

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 06 March 2024
Current Status: Taken in the Chamber on 14 March 2024

To ask the Scottish Government what it is doing to promote the uptake of the Scottish Child Payment.

Question reference: S6O-03142

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 21 February 2024
Current Status: Taken in the Chamber on 29 February 2024

To ask the Scottish Government what work has been done to improve accessibility to prescription wig provision for those affected by hair loss.

Question reference: S6O-02929

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 20 December 2023
Current Status: Taken in the Chamber on 10 January 2024

To ask the Scottish Government whether it will provide an update on how it plans to further invest in the culture sector.

Question reference: S6W-23411

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 29 November 2023
Current Status: Answered by Jenni Minto on 11 December 2023

To ask the Scottish Government what assessment it has made of making medicinal cannabis more widely available on the NHS for adults with epilepsy.

The Scottish Medicines Consortium (SMC) has accepted a cannabidiol (Epidyolex ® ) for three severe treatment-resistant epilepsies:

as adjunctive therapy of seizures associated with Dravet syndrome (DS) in conjunction with clobazam, for patients 2 years of age and older
as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) in conjunction with clobazam, for patients 2 years of age and older
as adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older

The biggest barrier to the prescribing of other Cannabis Based Products for Medicinal Use (CBPMs) on the NHS is that most products remain unlicensed with a limited, or non-existent, peer-reviewed clinical evidence base for their use.

The National Institute for Health Research (NIHR) is currently leading on the design of CBPM clinical trials into epilepsy. The Chief Pharmaceutical Officer continues to engage on the progress of these trials, which will be critical in building the evidence for CBPMs.

Question reference: S6O-02831

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 29 November 2023
Current Status: Taken in the Chamber on 6 December 2023

To ask the Scottish Government whether it will provide an update on the impact of its funding for humanitarian aid to Palestine.

Question reference: S6W-22950

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 15 November 2023
Current Status: Answered by Jenni Minto on 27 November 2023

To ask the Scottish Government what work is currently being undertaken to assess the possibility of making medicinal cannabis available on the NHS for those with chronic pain.

The National Institute for Health and Care Excellence (NICE) published a clinical guideline on the prescribing of Cannabis Based Products for Medicinal use (CBPMs) for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment resistant epilepsy on 11 November 2019, which was updated in October 2022. The guideline states that nabilone, dronabinol, delta-9-tetrahydrocannabinol (THC) or a combination of cannabidiol (CBD) with THC should not be offered to manage chronic pain in adults. Clinicians working in Scotland are expected to have regard to NICE guidance on CBPMs.

The Scottish Government and SIGN will both shortly be updating their chronic pain prescribing guides that will consider the evidence around the best and most effective treatments for chronic pain.

Question reference: S6O-02813

Asked by: Marie McNair, MSP for Clydebank and Milngavie, Scottish National Party
Date lodged: Wednesday, 22 November 2023
Current Status: Taken in the Chamber on 29 November 2023

To ask the Scottish Government whether it will provide an update on what it is doing to provide financial support to those infected with chronic hepatitis B due to receiving contaminated blood.